Sep 23, 2026 08:04AM
Sep 23, 2026 08:00AM
Aug 25, 2026 08:00AM
Jul 7, 2026 07:00AM
Jul 7, 2026 07:00AM
May 15, 2026 07:30AM
Apr 10, 2026 08:39AM Annovis Bio raises $10 million to fund alzheimer's drug development
Apr 10, 2026 08:31AM
Apr 10, 2026 08:30AM
Apr 10, 2026 08:30AM
Apr 8, 2026 09:15AM
Mar 19, 2026 07:31AM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 16, 2026 07:30AM
Feb 12, 2026 08:00AM
Feb 12, 2026 08:00AM
Dec 18, 2025 04:35PM
Dec 18, 2025 04:35PM Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
Dec 18, 2025 04:35PM
Nov 18, 2025 08:45AM
Nov 18, 2025 08:00AM
Nov 18, 2025 08:00AM
Nov 18, 2025 08:00AM
Nov 18, 2025 08:00AM
Sep 30, 2025 07:05AM Canaccord Genuity Reiterates Buy Rating on Annovis Bio Inc. (ANVS)
Aug 7, 2025 08:00AM
Aug 7, 2025 08:00AM
Jun 5, 2025 08:00AM
Jun 5, 2025 08:00AM
Mar 21, 2025 05:05PM
Feb 5, 2025 08:01AM
Feb 5, 2025 08:00AM Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease
Jan 7, 2025 08:01AM
Jan 7, 2025 08:00AM
Jan 7, 2025 08:00AM
Jan 7, 2025 08:00AM
Nov 25, 2024 08:00AM
Nov 11, 2024 08:00AM
Oct 31, 2024 08:00AM IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio
Oct 16, 2024 06:56AM
Oct 15, 2024 08:03AM
Oct 15, 2024 08:00AM
Oct 2, 2024 08:30AM
Sep 30, 2024 08:05AM
Sep 30, 2024 08:00AM
Sep 3, 2024 07:22AM Canaccord Genuity Reiterates Buy Rating on Annovis Bio Inc. (ANVS)
Aug 15, 2024 07:00AM

334,272 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All